Heart disease is once again the leading cause of death in the U.S., according to a new statistical report from the American ...

Drug manufacturer Novo Nordisk's amycretin, an experimental weight-loss pill in clinical trials, may boast substantial weight ...

Cries of outrage Chaos has taken place since Jan. 20 when the president took his oath. One issue near and dear to my heart is the ending of research information for cancer, diabetes, Parkinson’s, and ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...